Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy
10.1097/FM9.0000000000000207
- VernacularTitle:Clinical Management Guidelines for Intrahepatic Cholestasis of Pregnancy
- Author:
Xinyang YU
1
;
Huixia YANG
;
Hongbo QI
Author Information
1. Department of Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China
- Publication Type:Journal Article
- Keywords:
Cholestasis, Intrahepatic;
Bile Acids;
Stillbirth;
Preterm Birth;
Diagnostic and Therapeutic Guidelines (Theme)
- From:
Maternal-Fetal Medicine
2024;06(1):13-22
- CountryChina
- Language:English
-
Abstract:
Intrahepatic cholestasis of pregnancy (ICP) is a significant gestational complication in late pregnancy, potentially leading to severe perinatal complications such as intrauterine fetal demise and preterm birth. The Obstetrics Group of the Gynecology and Obstetrics Branch and the Perinatal Medicine Branch of the Chinese Medical Association organized a panel of domestic experts to deliberate and propose recommendations based on domestic and international guidelines, recent evidence-based medical evidence about key clinical issues including risk factors, clinical manifestations, perinatal outcomes, diagnosis, severity grading, maternal and fetal monitoring, treatment methods, timing, and methods of pregnancy termination, and postpartum follow-up for ICP, with the aim to guide its clinical diagnosis, treatment, and management.
